1061/1816US=56 / Biol/Mol
O'Brien MA, Moravec RA, Riss TL, Bulleit RF. Homogeneous, bioluminescent proteasome assays. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 163-81. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

20 ANOS PROTEASSOMA; BIOLUMINESCENCIA; LUCIFERASE; AMINOLUCIFERIN; ENSAIO PROTEASE BIOLUMINESCENTE; 20 ANOS ENSAIO PROTEASSOMA


1062/1816US=56 / Biol/Mol
Wang JW, Cheng JQ. A simple method for profiling miRNA expression. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 183-90. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

EXPRESSAO DE MIRNA; DOT BLOT; HIBRIDIZACAO; BIBLIOTECA OLIGODESOXINUCLEOTIDO


1063/1816US=56 / Biol/Mol
Denault JB, Salvesen GS. Apoptotic caspase activation and activity. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 191-220. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

CASPASE; SONDA; APOPTOSE; CASPASE; CINETICA


1064/1816US=56 / Biol/Mol
Walczak H, Haas TL. Biochemical analysis of the native TRAIL death-inducing signaling complex. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 221-39. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

TRAIL; APOPTOSE; DISC; IMUNOPRECIPITACAO; CASPASE


1065/1816US=56 / Biol/Mol
Vega CJ. Laser microdissection sample preparation for RNA analyses. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 241-52. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

MICRODISSECCAO A LASER; MICRODISSECCAO E CAPTURA A LASER (MCL); EXPRESSAO GENICA; RNA; RNASE


1066/1816US=64 / Câncer
Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR


1067/1816US=64 / Câncer
Langston AA, Francis D. Epidemiology of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 9-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

EPIDEMIOLOGIA; MIELOMA MULTIPLO


1068/1816US=64 / Câncer
Raab MS, Anderson KC. Basic biology of plasma cell dyscrasias: focus on the role of the tumor microenvironment. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 23-39. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BIOLOGIA BASICA DAS CELULAS PLASMATICAS DISCRASIAS; PAPEL DO MICROAMBIENTE TUMORAL


1069/1816US=64 / Câncer
Chng WJ, Bergsagel PL. Biology-based classification and staging of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 41-56. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BIOLOGIA BASEADA EM MIELOMA MULTIPLO; ESTADIAMENTO DO MIELOMA MULTIPLO


1070/1816US=64 / Câncer
Braggio E, Sebag M, Fonseca R. Cytogenetic abnormalities in multiple myeloma: the importance of FISH and cytogenetics. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 57-76. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANOMALIAS CITOGENETICAS EM MIELOMA MULTIPLO


1071/1816US=64 / Câncer
Harousseau JL. Role of autologous stem cell transplantation in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 79-90. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRANSPLANTE AUTOLOGO DE CELULAS-TRONCO NO MIELOMA MULTIPLO; TERAPIA DE ALTA DOSE; HDT; AUTOLOGO TRANSPLANTE DE CELULAS ESTAMINAIS


1072/1816US=64 / Câncer
Kaufman JL, Mihelic R, Lonial S. Maintenance therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 91-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA DE MANUTENCAO NO MIELOMA MULTIPLO


1073/1816US=64 / Câncer
Sara B, Antonio P. Therapy for patients not eligible for autologous transplant. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 99-112. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA PARA PACIENTES NAO COMPATIVEL TRANSPLANTE; TRANSPLANTE AUTOLOGO; QUIMIOTERAPIA CONVENCIONAL


1074/1816US=64 / Câncer
Ailawadhi S, Chanan-Khan A. Current role of anthracyclines in the treatment of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 113-21. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRATAMENTO DO MIELOMA MULTIPLO. ANTRACICLINAS; ANTRACICLINAS


1075/1816US=64 / Câncer
Wang F, Waller EK. Allogeneic transplantation for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 125-42. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRANSPLANTE ALOGENICO DE MIELOMA MULTIPLO; CLONAL DE CELULAS B; IMUNOTERAPIA ANTI MIELOMA


1076/1816US=64 / Câncer
Munshi NC, Tai YT. Antibody and other immune-based therapies for myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANTICORPOS; IMUNO-TERAPIAS BASEADAS PARA MIELOMA; ANTICORPOS CONTRA O TUMOR


1077/1816US=64 / Câncer
Badros A. Thalidomide in patients with relapsed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 205-27. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA EM PACIENTES MIELOMA MULTIPLO; TALIDOMIDA E MIELOMA


1078/1816US=64 / Câncer
Buadi FK, Rajkumar SV. Thalidomide: induction therapy. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 229-37. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA; TERAPIA DE INDUCAO; MIELOMA MULTIPLO; CLONAL DE CELULAS ESTAMINAIS


1079/1816US=64 / Câncer
Richardson PG, Mitsiades CS, Schlossman R, Hideshima T, Ghobrial I, Munshi NC, Anderson KC. The role of bortezomib in the treatment of relapsed and refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 239-52. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; MIELOMA MULTIPLO REFRACTARIO. TRATAMENTO


1080/1816US=64 / Câncer
San MFJ, Mateos MV. Bortezomib as induction therapy in patients with multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 253-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; PACIENTES COM MIELOMA MULTIPLO. TERAPIA DE INDUCAO


Primeira | Anterior | Próxima | Última